Cost-effectiveness of a high-intensity versus a low-intensity smoking cessation intervention in a dental setting: long-term follow-up. Issue 8 (15th August 2019)

• Record Type: Journal Article
• Authors: Feldman, Inna; Helgason, Asgeir Runar; Johansson, Pia; Tegelberg, Åke; Nohlert, Eva
• Is Part Of: BMJ open. Volume 9:Issue 8(2019)
• Publication Date: 2019-08-15
• Subjects: smoking cessation -- cost-effectivenes -- long-term sustainability; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2019-030934
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objectives: The aim of this study was to conduct a cost-effectiveness analysis (CEA) of a high-intensity and a low-intensity smoking cessation treatment programme (HIT and LIT) using long-term follow-up effectiveness data and to validate the cost-effectiveness results based on short-term follow-up. Design and outcome measures: Intervention effectiveness was estimated in a randomised controlled trial as numbers of abstinent participants after 1 and 5–8 years of follow-up. The economic evaluation was performed from a societal perspective using a Markov model by estimating future disease-related costs (in Euro (€) 2018) and health effects (in quality-adjusted life-years (QALYs)). Programmes were explicitly compared in an incremental analysis, and the results were presented as an incremental cost-effectiveness ratio. Setting: The study was conducted in dental clinics in Sweden. Participants: 294 smokers aged 19–71 years were included in the study. Interventions: Behaviour therapy, coaching and pharmacological advice (HIT) was compared with one counselling session introducing a conventional self-help programme (LIT). Results: The more costly HIT led to higher number of 6-month continuous abstinent participants after 1 year and higher number of sustained abstinent participants after 5–8 years, which translates into larger societal costs avoided and health gains than LIT. The incremental cost/QALY of HIT compared with LIT amounted to €918 and €3786 using short-term and long-term effectiveness, respectively, which is considered very cost-effective in Sweden. Conclusion: CEA favours the more costly HIT if decision makers are willing to spend at least €4000/QALY for tobacco cessation treatment.